Marsh McLennan (MRSH) is trading up at $178.40 (+0.79%) on NYSE/NASDAQ, as of the latest quote. It is a S&P 500 constituent in the Financials sector.
| FY2016Dec 2016 | FY2017Dec 2017 | FY2018Dec 2018 | FY2019Dec 2019 | FY2020Dec 2020 | FY2021Dec 2021 | FY2022Dec 2022 | FY2023Dec 2023 | FY2024Dec 2024 | FY2025Dec 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | $13.2B | $14.0B | $14.9B | $16.7B | $17.2B | $19.8B | $20.7B | $22.7B | $24.5B | $27.0B |
| Growth (year over year) | +2.5% | +6.2% | +6.6% | +11.4% | +3.4% | +15.1% | +4.5% | +9.7% | +7.6% | +10.3% |
| Operating income | $2.43B | $2.65B | $2.76B | $2.68B | $3.07B | $4.31B | $4.28B | $5.28B | $5.82B | $6.22B |
| Operating margin | 18.4% | 18.9% | 18.5% | 16.1% | 17.8% | 21.8% | 20.7% | 23.2% | 23.8% | 23.1% |
| Net income | $1.77B | $1.49B | $1.65B | $1.74B | $2.02B | $3.14B | $3.05B | $3.76B | $4.06B | $4.16B |
| Net margin | 13.4% | 10.6% | 11.0% | 10.5% | 11.7% | 15.9% | 14.7% | 16.5% | 16.6% | 15.4% |
| EPS (diluted) | $3.38 | $2.87 | $3.23 | $3.41 | $3.94 | $6.13 | $6.04 | $7.53 | $8.18 | $8.43 |
| Balance sheet | ||||||||||
| Cash and equivalents | $1.03B | $1.21B | $1.07B | $1.16B | $2.09B | $1.75B | $1.44B | $3.36B | $2.40B | $2.69B |
| Total assets | $18.2B | $20.4B | $21.6B | $31.4B | $33.0B | $44.0B | $44.1B | $48.0B | $56.5B | $58.7B |
| Total liabilities | $11.9B | $13.0B | $14.0B | $23.4B | $23.8B | $23.2B | $33.4B | $35.7B | $42.9B | $43.4B |
| Long-term debt | $4.50B | $5.22B | $5.51B | $10.7B | $10.8B | $10.9B | $11.2B | $11.8B | $19.4B | $18.3B |
| Shareholders' equity | $6.27B | $7.44B | $7.58B | $7.94B | $9.26B | $11.2B | $10.7B | $12.4B | $13.5B | $15.3B |
| Cash flow | ||||||||||
| Operating cash flow | $2.01B | $1.89B | $2.43B | $2.36B | $3.38B | $3.52B | $3.46B | $4.26B | $4.30B | $5.29B |
| Capital expenditure | $253.0M | $302.0M | $314.0M | $421.0M | $348.0M | $406.0M | $470.0M | $416.0M | $316.0M | $291.0M |
| Free cash flow | $1.75B | $1.59B | $2.11B | $1.94B | $3.03B | $3.11B | $3.00B | $3.84B | $3.99B | $5.00B |
| Dividends paid | $682.0M | $740.0M | $807.0M | $890.0M | $943.0M | $1.03B | $1.14B | $1.30B | $1.51B | $1.70B |
| Share buybacks | $800.0M | $900.0M | $675.0M | $485.0M | $0 | $1.16B | $1.95B | $1.15B | $900.0M | $2.01B |
| Q3 FY24Sep 2024 | Q4 FY24†Dec 2024 | Q1 FY25Mar 2025 | Q2 FY25Jun 2025 | Q3 FY25Sep 2025 | Q4 FY25†Dec 2025 | Q1 FY26Mar 2026 | Q2 FY26Jun 2026 | |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | $5.70B | $6.07B | $7.06B | $6.97B | $6.35B | $6.59B | $7.60B | $7.40B |
| Growth (year over year) | +5.9% | +9.2% | +9.1% | +12.1% | +11.5% | +8.7% | +7.6% | +6.2% |
| Operating income | $1.11B | $1.14B | $2.00B | $1.83B | $1.17B | $1.22B | $1.75B | $1.90B |
| Operating margin | 19.4% | 18.8% | 28.4% | 26.2% | 18.4% | 18.5% | 23.1% | 25.6% |
| Net income | $747.0M | $788.0M | $1.38B | $1.21B | $747.0M | $821.0M | $1.15B | $1.27B |
| Net margin | 13.1% | 13.0% | 19.6% | 17.4% | 11.8% | 12.4% | 15.1% | 17.1% |
| EPS (diluted) | $1.51 | $1.58 | $2.79 | $2.45 | $1.51 | $1.68 | $2.36 | $2.63 |
| Balance sheet | ||||||||
| Cash and equivalents | $1.80B | $2.40B | $1.60B | $1.68B | $2.51B | $2.69B | $1.61B | $1.70B |
| Total assets | $49.9B | $56.5B | $57.0B | $58.6B | $58.8B | $58.7B | $58.6B | $59.7B |
| Total liabilities | $36.0B | $42.9B | $42.7B | $42.6B | $43.4B | $43.4B | $43.7B | $44.2B |
| Long-term debt | $12.3B | $19.4B | $18.9B | $19.0B | $18.3B | $18.3B | $18.9B | $18.9B |
| Shareholders' equity | $13.9B | $13.5B | $14.3B | $16.0B | $15.4B | $15.3B | $14.8B | $15.4B |
| Cash flow | ||||||||
| Operating cash flow | $1.91B | $1.96B | −$622.0M | $1.67B | $2.08B | $2.16B | −$688.0M | $1.52B |
| Capital expenditure | $73.0M | $76.0M | $55.0M | $59.0M | $72.0M | $105.0M | $62.0M | $72.0M |
| Free cash flow | $1.84B | $1.88B | −$677.0M | $1.61B | $2.01B | $2.06B | −$750.0M | $1.45B |
| Dividends paid | $404.0M | $403.0M | $405.0M | $405.0M | $445.0M | $444.0M | $440.0M | $438.0M |
| Share buybacks | $300.0M | $0 | $300.0M | $300.0M | $402.0M | $1.01B | $755.0M | $757.0M |
From Marsh McLennan's 10-K and 10-Q filings with the SEC; its fiscal year ends in December. Each period shows the latest figure the company has reported for it, including restatements. Net margin is our own calculation from those reported figures (net income ÷ revenue); it is left blank where revenue is zero or missing. † Quarter derived from the company's year-to-date or full-year totals. Filings on SEC EDGAR →
Marsh & McLennan Companies, Inc., trading as Marsh McLennan and Marsh, is an American professional services firm headquartered in New York City, with businesses in insurance brokerage, risk management, reinsurance services, talent management, investment advisory, and management consulting. Its four main operating companies are Marsh, which offers risk management, insurance broking, insurance program management, risk consulting, analytical modeling, and alternative risk financing services; Marsh Re, a reinsurance intermediary and advisor; Mercer, which provides consulting to employers for health insurance, retirement plans, and pension plans; and Oliver Wyman, including Lippincott and NERA Economic Consulting, which provides consulting services. In 2024, risk and insurance services contributed a total of 63% of revenues and 71% of operating profit, while consulting contributed 37% of revenues and 29% of operating profit. It is the largest insurance broker worldwide.
Source: Wikipedia — Marsh McLennan